Pro-surfactant protein B as a biomarker for lung cancer prediction

Journal of Clinical Oncology

Volumn 31, Issue 36, 2013, Pages 4536-4543

  Sin, Don ^a,b   Tammemagi, C Martin ^d   Lam, Stephen ^a,c   Barnett, Matt J ^e   Duan, Xiaobo ^c   Tam, Anthony ^a,b   Auman, Heidi ^f   Feng, Ziding ^e,g   Goodman, Gary E ^e   Hanash, Samir ^g   Taguchi, Ayumu ^g  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UBC James Hogg Research Centre St Paul's Hospital   (United States)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d BROCK UNIVERSITY   (Canada)

^e Fred Hutchinson Cancer Research Center   (United States)

^f Canary Foundation   (United States)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRO SURFACTANT PROTEIN B; SURFACTANT PROTEIN B; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; BETA CAROTENE; PRO-SFTPB PROTEIN, HUMAN; PROTEIN PRECURSOR; SURFACTANT ASSOCIATED PROTEIN; TUMOR MARKER; PRO SFTPB PROTEIN, HUMAN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CANCER RISK; FAMILY HISTORY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SMOKING; BLOOD; CANADA; CARCINOMA, NON-SMALL-CELL LUNG; CASE CONTROL STUDY; EARLY DIAGNOSIS; EVALUATION STUDY; LUNG NEOPLASMS; MIDDLE AGED; MULTICENTER STUDY (TOPIC); MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; STATISTICAL MODEL; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METHODOLOGY;

AGED; ANTICARCINOGENIC AGENTS; AREA UNDER CURVE; BETA CAROTENE; CANADA; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84894459721     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.50.6105     Document Type: Article

References (21)

1. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62:10-29, 2012
2. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al: Reduced lungcancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395-409, 2011
3. Goulart BH, Bensink ME, Mummy DG, et al: Lung cancer screening with low-dose computed tomography: Costs, national expenditures, and costeffectiveness. J Natl Compr Canc Netw 10:267-275, 2012
4. Guttentag S, Robinson L, Zhang P, et al: Cysteine protease activity is required for surfactant protein B processing and lamellar body genesis. Am J Respir Cell Mol Biol 28:69-79, 2003 (Pubitemid 36017052)
5. Khoor A, Whitsett JA, Stahlman MT, et al: Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesothelioma. Hum Pathol 30:695-700, 1999 (Pubitemid 29266730)
6. O'Reilly MA, Gazdar AF, Clark JC, et al: Glucocorticoids regulate surfactant protein synthesis in a pulmonary adenocarcinoma cell line. Am J Physiol 257:L385-L392, 1989
7. Taguchi A, Politi K, Pitteri SJ, et al: Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. Cancer Cell 20: 289-299, 2011
8. Tammemagi CM, Pinsky PF, Caporaso NE, et al: Lung cancer risk prediction: Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst 103:1058-1068, 2011
9. Tammemägi M, Katki HA, Hocking WG, et al: Selection criteria for lung-cancer screening. N Engl J Med 368:728-736, 2013
10. Miller MR, Hankinson J, Brusasco V, et al: Standardisation of spirometry. Eur Respir J 26:319-338, 2005 (Pubitemid 41079078)
11. McWilliams A, Tammemagi M, Mayo JR, et al: Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 369:910-919, 2013
12. Goodman GE, Thornquist MD, Balmes J, et al: The Beta-Carotene and Retinol Efficacy Trial: Incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping betacarotene and retinol supplements. J Natl Cancer Inst 96:1743-1750, 2004 (Pubitemid 39654568)
13. Royston P, Sauerbrei W: Multivariable Model- Building: A Pragmatic Approach to Regression Analysis Based on Fractional Polynomials for Modelling Continuous Variables. Chichester, West Sussex, United Kingdom, John Wiley & Sons, 2008
14. Pepe M, Longton G, Janes H: Estimation and comparison of receiver operating characteristic curves. Stata J 9:1-16, 2009
15. Harrell FE Jr: Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY, Springer-Verlag, 2001
16. Ikeda M, Itoh S, Ishigaki T, et al: Application of resampling techniques to the statistical analysis of the Brier score. Methods Inf Med 40:259-264, 2001 (Pubitemid 32701487)
17. Harrell FE Jr: Regression Modeling Strategies: Package 'rms'. 2010:1-217
18. Lam S, Boyle P, Healey GF, et al: EarlyCDTLung: An immunobiomarker test as an aid to early detection of lung cancer. Cancer Prev Res (Phila) 4:1126-1134, 2011
19. Whitsett JA, Glasser SW: Regulation of surfactant protein gene transcription. Biochim Biophys Acta 1408:303-311, 1998 (Pubitemid 28517875)
20. Stahlman MT, Gray ME, Whitsett JA: Expression of thyroid transcription factor-1 (TTF-1) in fetal and neonatal human lung. J Histochem Cytochem 44:673-678, 1996 (Pubitemid 26240774)
21. Wert SE, Dey CR, Blair PA, et al: Increased expression of thyroid transcription factor-1 (TTF-1) in respiratory epithelial cells inhibits alveolarization and causes pulmonary inflammation. Dev Biol 242:75-87, 2002 (Pubitemid 34163972)